Get the Stockscreener App
1.76
0.56%
-0.01
Pacific Biosciences Of California Inc Stock (PACB) Forecast
The Pacific Biosciences Of California Inc (PACB) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.2539, representing a -85.57% decrease from the current price of $1.76. The highest analyst price target is $0.3488, and the lowest is $0.159.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PACB Price Target
Average 2.8225
(+60.37% Upside)
Is Pacific Biosciences Of California Inc (PACB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 43.66 | Neutral |
| STOCH(9,6) | 37.35 | Neutral |
| STOCHRSI(14) | 27.48 | Neutral |
| MACD(12,26) | -0.0688 | Sell |
| ADX(14) | 18.00 | Neutral |
| William %R | -76.92 | Neutral |
| CCI(14) | -38.32 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.741
Buy
|
1.8273
Sell
|
| MA20 |
2.0563
Sell
|
1.9041
Sell
|
| MA50 |
1.9082
Sell
|
1.9007
Sell
|
| MA100 |
1.7867
Sell
|
2.0084
Sell
|
| MA200 |
2.2815
Sell
|
3.1415
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, PACB could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on PACB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 43.66 indicates that PACB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 37.35 indicates that PACB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 27.48 indicates that PACB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 18 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -38.32 indicates that PACB is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term PACB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Pacific Biosciences Of California Inc financial reports and earnings history, Pacific Biosciences Of California Inc (PACB) stock could reach $4.3213 by 2030, $5.0877 by 2040 and $5.05 by 2050. See the projected annual prices until 2050 of the Pacific Biosciences Of California Inc stock below:
- Pacific Biosciences Of California Inc (PACB) is expected to reach an average price of $5.1127 in 2035, with a high prediction of $5.2777 and a low estimate of $2.2134. This indicates an $190.49% rise from the last recorded price of $1.76.
- Pacific Biosciences Of California Inc (PACB) stock is projected to chart a bullish course in 2040, with an average price target of $3.9269, representing an $123.12% surge from its current level. The forecast ranges from a conservative $3.1769 to a sky-high $5.0877.
- Our analysts predict Pacific Biosciences Of California Inc (PACB) to jump 169.93% by 2045, soaring from $5.2692 to an average price of $4.7507, potentially reaching $4.8702. While $5.2692 is the low estimate, the potential upside is significant.
- Pacific Biosciences Of California Inc (PACB) stock is expected to climb by 2050, reaching an average of $5.31, a $201.71% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.05 and $5.1231, respectively, highlighting the market's uncertainty.
Pacific Biosciences Of California Inc Stock (PACB) Year by Year Forecast
Pacific Biosciences Of California Inc Stock (PACB) Price Forecast for 2024
Our forecast for PACB stock price in 2024 now indicates an average price target of $5.0063 with a high forecast of $9.99 and a low forecast of $0.0226. The average prediction reflects an increase of +184.45% from the last recorded price of $1.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $0.1642 | $0.159 | $0.3488 | -90.67% |
Pacific Biosciences Of California Inc Stock (PACB) Price Forecast for 2025
Pacific Biosciences Of California Inc Stock (PACB) is expected to reach an average price of $5.3573 in 2025, with a high prediction of $10.71 and a low estimate of $0.00532. This indicates an +204.39% rise from the last recorded price of $1.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.1702 | $0.00532 | $0.5356 | -90.33% |
| February, 2025 | $0.3953 | $0.1598 | $0.2351 | -77.54% |
| March, 2025 | $1.6458 | $0.3554 | $0.8658 | -6.49% |
| April, 2025 | $1.9315 | $1.7859 | $2.0162 | +9.74% |
| May, 2025 | $1.652 | $1.797 | $1.8116 | -6.14% |
| June, 2025 | $1.3175 | $1.5325 | $1.5492 | -25.14% |
| July, 2025 | $1.1931 | $1.2328 | $1.0177 | -32.21% |
| August, 2025 | $0.9486 | $0.9636 | $1.1584 | -46.10% |
| September, 2025 | $0.1259 | $0.8641 | $0.759 | -92.85% |
| October, 2025 | $1.9403 | $0.1542 | $2.7203 | +10.24% |
| November, 2025 | $5.3997 | $1.6651 | $5.6397 | +206.80% |
| December, 2025 | $8.7141 | $5.5146 | $10.71 | +395.12% |
Pacific Biosciences Of California Inc Stock (PACB) Price Forecast for 2026
The predicted value for Pacific Biosciences Of California Inc (PACB) in 2026 is set at an average of $28.19. Estimates vary from a peak of $49.53 to a trough of $6.839, indicating an +1,501% surge from the present price of $1.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $11.09 | $6.839 | $12.77 | +530.32% |
| February, 2026 | $15.78 | $10.87 | $19.39 | +796.77% |
| March, 2026 | $32.71 | $15.59 | $36.55 | +1,758% |
| April, 2026 | $38.89 | $24.56 | $49.53 | +2,109% |
| May, 2026 | $29.35 | $20.65 | $37.49 | +1,567% |
| June, 2026 | $28.14 | $22.38 | $33.40 | +1,499% |
| July, 2026 | $19.61 | $16.27 | $30.86 | +1,014% |
| August, 2026 | $25.33 | $18.71 | $26.25 | +1,339% |
| September, 2026 | $28.14 | $22.80 | $32.51 | +1,499% |
| October, 2026 | $28.55 | $21.45 | $31.82 | +1,522% |
| November, 2026 | $27.61 | $21.80 | $29.83 | +1,469% |
| December, 2026 | $21.93 | $20.69 | $28.87 | +1,146% |
Pacific Biosciences Of California Inc Stock (PACB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Pacific Biosciences Of California Inc (PACB) is $14.22, with a high forecast of $27.57 and a low forecast of $0.8671. This indicates an +707.78% increase from the last price of $1.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $21.91 | $20.02 | $22.67 | +1,145% |
| February, 2027 | $22.97 | $20.99 | $27.57 | +1,205% |
| March, 2027 | $17.61 | $14.83 | $22.85 | +900.62% |
| April, 2027 | $9.0604 | $8.6704 | $18.97 | +414.79% |
| May, 2027 | $7.5399 | $5.7001 | $9.1553 | +328.40% |
| June, 2027 | $7.4442 | $6.1945 | $9.3942 | +322.97% |
| July, 2027 | $5.9237 | $5.054 | $8.3291 | +236.58% |
| August, 2027 | $3.7032 | $3.4332 | $7.3285 | +110.41% |
| September, 2027 | $3.1276 | $1.4379 | $4.653 | +77.70% |
| October, 2027 | $1.2571 | $0.8671 | $3.1225 | -28.57% |
| November, 2027 | $2.5266 | $1.1968 | $2.9166 | +43.56% |
| December, 2027 | $5.941 | $0.9963 | $11.35 | +237.55% |
Pacific Biosciences Of California Inc Stock (PACB) Price Forecast for 2028
In 2028, Pacific Biosciences Of California Inc (PACB) is projected to reach an average price of $7.2173, with a high projection of $12.19 and a low estimate of $2.2399. This indicates an +310.07% rise from the last price of $1.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.5304 | $2.2754 | $6.4158 | +43.78% |
| February, 2028 | $3.0749 | $2.2399 | $4.3953 | +74.71% |
| March, 2028 | $5.7843 | $2.7448 | $6.5844 | +228.65% |
| April, 2028 | $7.5138 | $5.0092 | $9.7589 | +326.92% |
| May, 2028 | $5.9682 | $5.8182 | $8.7186 | +239.10% |
| June, 2028 | $8.8277 | $5.203 | $10.08 | +401.57% |
| July, 2028 | $7.6572 | $7.2172 | $9.9323 | +335.07% |
| August, 2028 | $5.9715 | $5.6815 | $8.802 | +239.29% |
| September, 2028 | $8.691 | $5.8413 | $9.5011 | +393.81% |
| October, 2028 | $9.9805 | $7.6256 | $10.49 | +467.07% |
| November, 2028 | $11.35 | $9.4304 | $11.40 | +545.16% |
| December, 2028 | $11.22 | $10.03 | $12.19 | +537.75% |
Pacific Biosciences Of California Inc Stock (PACB) Price Forecast for 2029
The 2029 price forecast for Pacific Biosciences Of California Inc Stock (PACB) is $6.2829 on average, with a high prediction of $12.52 and a low estimate of $0.0468. This represents an +256.98% increase from the previous price of $1.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $11.21 | $10.05 | $12.52 | +536.86% |
| February, 2029 | $7.9782 | $7.9532 | $11.37 | +353.31% |
| March, 2029 | $8.5377 | $7.8431 | $10.07 | +385.10% |
| April, 2029 | $6.1572 | $5.8323 | $8.5026 | +249.84% |
| May, 2029 | $4.7716 | $3.9767 | $6.6121 | +171.11% |
| June, 2029 | $7.1911 | $4.4415 | $7.2712 | +308.58% |
| July, 2029 | $8.1806 | $6.1308 | $9.0206 | +364.81% |
| August, 2029 | $4.9549 | $4.4252 | $8.3755 | +181.53% |
| September, 2029 | $3.6144 | $3.5044 | $5.4648 | +105.37% |
| October, 2029 | $2.2588 | $2.1138 | $4.6093 | +28.34% |
| November, 2029 | $0.1883 | $0.1117 | $2.4837 | -89.30% |
| December, 2029 | $3.985 | $0.0468 | $3.93 | +126.42% |
Pacific Biosciences Of California Inc Stock (PACB) Price Forecast for 2030
Pacific Biosciences Of California Inc Stock (PACB) is expected to reach an average price of $5.5438 in 2030, with a high forecast of $6.9624 and a low forecast of $4.1253. This signifies an +214.99% surge from the last price of $1.76.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.5463 | $4.1253 | $4.3213 | +158.31% |
| February, 2030 | $5.1273 | $5.1315 | $4.9523 | +191.32% |
| March, 2030 | $5.5133 | $5.7733 | $5.6528 | +213.26% |
| April, 2030 | $5.3143 | $5.279 | $5.1843 | +201.95% |
| May, 2030 | $5.5206 | $5.2946 | $5.4281 | +213.67% |
| June, 2030 | $5.8366 | $5.5063 | $5.5008 | +231.62% |
| July, 2030 | $5.2228 | $5.6871 | $5.6968 | +196.75% |
| August, 2030 | $5.0089 | $5.3386 | $5.2031 | +184.59% |
| September, 2030 | $5.4499 | $5.1091 | $4.8794 | +209.65% |
| October, 2030 | $5.4611 | $5.225 | $5.4511 | +210.29% |
| November, 2030 | $6.9771 | $5.8614 | $6.0721 | +296.43% |
| December, 2030 | $7.1532 | $7.1829 | $6.9624 | +306.43% |
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):